References
Pardini M, Huey ED, Spina S, Kreisl WC, Morbelli S, Wassermann EM, et al. FDG-PET patterns associated with underlying pathology in corticobasal syndrome. Neurology. 2019;92:e1121–e35.
Chand P, Grafman J, Dickson D, Ishizawa K, Litvan I. Alzheimer’s disease presenting as corticobasal syndrome. Move Disord. 2006;21:2018–22.
Cilia R, Rossi C, Frosini D, Volterrani D, Siri C, Pagni C, et al. Dopamine transporter SPECT imaging in corticobasal syndrome. PLoS One. 2011;6:e18301.
O’Sullivan SS, Burn DJ, Holton JL, Lees AJ. Normal dopamine transporter single photon-emission CT scan in corticobasal degeneration. Move Disord. 2008;23:2424–6.
Jin S, Oh M, Oh SJ, Oh JS, Lee SJ, Chung SJ, et al. Additional value of early-phase 18F-FP-CIT PET image for differential diagnosis of atypical parkinsonism. Clin Nucl Med. 2017;42:e80–e8.
Acknowledgements
This research was partly supported by the Basic Science Research Program through.
the National Research Foundation of Korea funded by the Ministry of Education.
(No. NRF-2017R1C1B5018378 (J.H.Y), NRF-2018M3A9E8023859 (J.H.Y).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Relevant conflicts of interests/financial disclosures
The authors have nothing to declare.
Informed consent
Written informed consent was obtained from the spouse of the subject for publication of this case report and accompanying images.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Image of the Month
Rights and permissions
About this article
Cite this article
Yoon, J.H., Ahn, Y.S. Dual-phase 18F-FP-CIT PET in corticobasal syndrome underlying AD pathology. Eur J Nucl Med Mol Imaging 46, 2208–2209 (2019). https://doi.org/10.1007/s00259-019-04376-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-019-04376-7